NCT00530972View on ClinicalTrials.gov

Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous Therapies

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Chronic Hepatitis CHIV Infections
Interventions
DRUG

Peginterferon alfa-2a plus ribavirin adjusted to body weight

PegInterferon 180 mcg/week, Adjusted body weight Ribavirin (1000 mg \<75 kg, 1200 mg \>75 kg)

Trial Locations (1)

28029

Hospital Carlos III, Madrid

All Listed Sponsors
lead

Hospital Carlos III, Madrid

OTHER

NCT00530972 - Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous Therapies | Biotech Hunter | Biotech Hunter